NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘pharmaceuticals’

29 August 2014

Venture capital-backed Rhythm files for Nasdaq IPO

nasdaq Venture capital-backed metabolic drug developer Rhythm has filed for an IPO on the Nasdaq exchange.

28 August 2014

Biotech startup Armetheon raises $7m Series A

medic Menlo Park-based biopharmaceutical startup Armetheon has raised $7m in a Series A round led by AshHill Biomedical Investments and Hercules Bioventures.

28 August 2014

RA Capital, Redmile in huge $55m Series C for cancer-fighting biotech business

cancer juno RA Capital Management and Redmile Group were among 11 new investors in a $55m Series C financing round for biotech company Bellicum Pharmaceuticals.

26 August 2014

Gimv exits Covagen after six years

covagen Investment firm Gimv has exited its portfolio company Covagen to an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson after more than six years.

26 August 2014

Canaan, Correlation Ventures in $24m Series B for pharma company

pills-755958-m Canaan Partners and Correlation Ventures have re-upped in a $24m Series B financing round for medical company Aldea Pharmaceuticals.

11 August 2014

Business Growth Fund invests £2m in UK buy-and-build pharma company

pills-1111307-m British investment firm the Business Growth Fund has invested £2m in specialist pharmaceutical company Abbey Pharma.

8 August 2014

Beringea exits pharmaceutical company Altacor after seven years

Cataract-surgery UK-bases growth capital investor Beringea has sold its investment in specialty ophthalmology company Altacor to Dutch life sciences investment firm Esperante after seven years of ownership.

4 August 2014

KKR, Warburg Pincus among suitors for GSK, Sanofi drugs

pills Private equity firms are reportedly planning to buy older drugs from pharmaceutical groups GlaxoSmithKline and Sanofi and merge them.

1 August 2014

Polaris hires ex-Pfizer exec Amy Schulman as venture partner

schulman Boston-based investment firm Polaris Partners has hired ex-Pfizer executive Amy Schulman as a venture partner.

28 July 2014

Sanofi’s $8.5bn mature drug portfolio draws private equity interest

green pills A trio of private equity majors are reportedly interested in French pharmaceutical company Sanofi’s $8.5bn portfolio of older, off-patent drugs.

Page 1 of 612345...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014